Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2026 / February / More Than Nerves: Rethinking NK Pathology
Neuro-ophthalmology Research & Innovations News

More Than Nerves: Rethinking NK Pathology

Are neurotrophic keratitis and limbal stem cell deficiency more pathologically linked than previously assumed?

2/24/2026 1 min read

Share

  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll
  • Top Institutions

Clinical Scorecard: More Than Nerves: Rethinking NK Pathology

At a Glance

CategoryDetail
ConditionNeurotrophic Keratitis (NK)
Key MechanismsCorneal nerve loss, limbal stem cell deficiency, immune dysregulation
Target PopulationPatients with Neurotrophic Keratitis
Care SettingOphthalmology clinics

Key Highlights

  • Profound corneal nerve loss and marked depletion of limbal epithelial stem cells (LESCs) observed in NK patients.
  • Increased dendritic cell (DC) density and activation linked to inflammation and epithelial failure.
  • Recombinant human nerve growth factor (rhNGF) shows potential in improving LESC density and reducing inflammation.
  • Corneal nerve regeneration follows LESC recovery, indicating a complex interplay between nerves, stem cells, and immune response.
  • NK is reframed as a multisystem ocular surface disease, necessitating broader assessment and management strategies.

Guideline-Based Recommendations

Diagnosis

  • Assess corneal nerve fiber density and LESC density using in vivo confocal microscopy.

Management

  • Consider topical rhNGF (cenegermin) for patients with stage 3-4 NK to promote cellular recovery.

Monitoring & Follow-up

  • Monitor changes in LESC density, DC activation, and corneal staining scores over time.

Risks

  • Incomplete normalization of corneal nerve and LESC parameters despite treatment.

Patient & Prescribing Data

Patients with stage 3-4 Neurotrophic Keratitis

rhNGF may stabilize the limbal microenvironment and suppress inflammation, facilitating recovery.

Clinical Best Practices

  • Evaluate limbal health as part of NK assessment.
  • Incorporate strategies to manage inflammation in NK treatment plans.
  • Recognize the importance of a regenerative feedback loop involving nerves, stem cells, and immune cells.

References

  • American Journal of Ophthalmology

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: